26 July 2026 12:00 AM
Individualized genetic medicines may address exceptionally rare disorders, but evidence, manufacturing, safety, access, and regulation remain difficult.
25 July 2026 12:00 AM
Bayesian trial methods can integrate prior evidence, support adaptive decisions, and sharpen uncertainty estimates during therapeutic development.
24 July 2026 12:00 AM
An examination of how artificial intelligence can support health policy analysis while introducing new requirements for transparency, oversight, and equity.
23 July 2026 12:00 AM
Practical, evidence-based strategies for building a sustainable eating routine without relying on rigid rules or constant willpower.
23 July 2026 12:00 AM
An evidence-based overview of how organoids improve disease modeling, drug testing, personalized research, and regenerative medicine.
22 July 2026 12:00 AM
An evidence-based overview of how molecular and clinical data can inform diagnosis, treatment selection, risk assessment, and monitoring.